Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
Vivani Medical, Inc. (EYES)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2023 |
4
| Williams Gregg (10% Owner) has filed a Form 4 on Vivani Medical, Inc.|
Txns:
| Bought 3,048 shares
@ $1, valued at
$3k
Bought 5,452 shares
@ $1, valued at
$5.5k
Bought 1,424 shares
@ $1, valued at
$1.4k
|
|
| 10/02/2023 |
4
| Williams Gregg (10% Owner) has filed a Form 4 on Vivani Medical, Inc.|
Txns:
| Bought 20,003 shares
@ $1.03, valued at
$20.6k
Bought 16,207 shares
@ $1, valued at
$16.2k
|
|
| 09/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/10/2023 |
8-K
| Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...|
Docs:
|
"ARTICLE I",
"VIVANI MEDICAL, INC. PLAN OF CONVERSION This Plan of Conversion sets forth certain terms of the conversion of Vivani Medical, Inc. , a California corporation , to a Delaware corporation , pursuant to the terms of the California Corporations Code and the General Corporation Law of the State of Delaware . WITNESSETH: WHEREAS, the California Corporation was incorporated on May 22, 2003; WHEREAS, upon the terms and subject to the conditions set forth in this Plan, and in accordance with Section 1152 of the CCC and Section 265 of the DGCL, the California Corporation will be converted to a Delaware Corporation; WHEREAS, the board of directors of the California Corporation has unanimously determined that the Conversion is advisable and in the best interests of the California Corporation and its s..." |
|
| 06/29/2023 |
4
| Makes Brigid (CFO) has filed a Form 4 on Vivani Medical, Inc.|
Txns:
| Bought 1,000 shares
@ $1.24, valued at
$1.2k
Bought 3,000 shares
@ $1.21, valued at
$3.6k
|
|
| 06/16/2023 |
8-K
| Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits Interactive Data |
| 06/12/2023 |
4
| Mendelsohn Aaron (Director) has filed a Form 4 on Vivani Medical, Inc.|
Txns:
| Bought 10,000 shares
@ $1.298, valued at
$13k
|
|
| 05/15/2023 |
8-K
| Quarterly results|
Docs:
|
"Vivani Medical, Inc. Guaranteed Adherence. Better Outcomes. Nasdaq: VANI May 15, 2023 www.vivani.com",
"VIVANI MEDICAL, INC. AND SUBSIDIARIES Condensed Consolidated Balance Sheets March 31, 2023 December 31, 2022 ASSETS Current assets: Cash and cash equivalents $ 38,073 $ 45,076 Prepaid expenses and other current assets 2,611 2,452 Total current assets 40,684 47,528 Property and equipment, net 1,111 1,182 Right-of-use assets 1,148 779 Restricted cash 1,366 1,366 Deposits and other assets 271 275 Total assets $ 44,580 $ 51,130 LIABILITIE S AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable $ 746 $ 1,177 Accrued expenses 2,114 2,358 Litigation accrual 1,675 1,675 Accrued compensation expense 415 657 Current operating lease liabilities 913 955 Total current liabilities 5,863 6,822 Long term operating lease liabilities 349 — Total liabilities 6,212 6,822 Commitments and contingencie..." |
|
| 05/15/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/01/2023 |
ARS/A
| Form ARS/A - Annual Report to Security Holders: [Amend] |
| 05/01/2023 |
DEFR14A
| Form DEFR14A - Revised definitive proxy soliciting materials: |
| 04/28/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/28/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/28/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/25/2023 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 03/31/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/21/2023 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits Inte...|
Docs:
|
"TRANSITION FUNDING, SUPPORT AND SERVICES AGREEMENT This TRANSITION FUNDING, SUPPORT AND SERVICES AGREEMENT , dated as of March 19, 2023 , is by and between Vivani Medical, Inc., a California corporation , and Cortigent, Inc., a Delaware corporation . Parent and Cortigent may be referred to herein individually as a “ Party ” and collectively as the “ Parties ”. R E C I T A L S WHEREAS, Cortigent is presently a wholly owned subsidiary of Parent formerly known as Second Sight Medical Products, Inc. ; WHEREAS Cortigent includes the personnel, technologies, intellectual property and other assets that formerly comprised Second Sight; WHEREAS, Cortigent is a pioneer in developing targeted neurostimulation systems to provide artificial vision to blind persons and is developing new medical device s...",
"Vivani Medical, Inc. Guaranteed Adherence. Better Outcomes. Nasdaq: VANI March 21, 2023 www.vivani.com",
"Investor Contact:" |
|
|
|
|